Wednesday, 8 January, 2025

Biomatlante MBCP bone graft substitute

MBCP synthetic bone substitute is a biphasic calcium phosphate ceramic composed of 60% hydroxyapatite (HA) and 40% tricalcium phosphate beta (TCP). HA is the closest synthetic equivalent to human bone mineral (biological apatite crystals), is biocompatible and bioactive in vivo. TCP is recognized to have great bioactivity and fast dissolution to promote ionic exchange. MBCP is indicated for all bone defects; extraction sockets; sinus floor augmentation; intraosseus defects; ridge augmentation; defects around implant; and ridge reconstruction. The effectiveness of MBCP Bone Graft Substitute has been critically evaluated during more than 25 years of clinical studies.

Biomatlante MBCP bone graft substitute

Type Bone Graft Substitute
Composition 60% hydroxyapatite (HA)
40% tricalcium phosphate beta (TCP)
Integration Time Variable (patient specific)
Membrane Size N/A
Particle Size 250-1,000 microns (Granules S)
1,000 - 2,000 microns (Granules L)
Indications Bone defects
Extraction sockets
Sinus floor augmentation
Intraosseus defects
Ridge augmentation
Defects around implant
Ridge reconstruction
Packaging
Video
Country of Manufacture France

Biomatlante MBCP Technology

Animation of the biological process on the MBCP bone graft, once implanted.

Add to Compare List

Manufacturer

Distributors - AUSTRALIA

Abstracts

Staying Safe

Clinical

Clinical

Stream the latest dental videos...
VITA ENAMIC Reworking Tutorial

Sponsored Links...

Upcoming Events...

Jan 01 2025
Jan 21 2025
Feb 06 2025
Feb 07 2025
Feb 12 2025
Feb 18 2025

Siberian Dental Forum 2025

Krasnoyarsk, RUSSIA

Feb 27 2025

Maximising Recall Compliance

Live Online, AUSTRALIA

Mar 15 2025
Mar 25 2025

IDS 2025

Cologne, GERMANY

Mar 29 2025
May 08 2025
May 30 2025
Jun 07 2025
Jun 21 2025
Sep 13 2025
Sep 20 2025
Oct 16 2025

ADOHTA-DHAA 2025 National Congress

Gold Coast, AUSTRALIA

Mar 20 2026
Apr 17 2026

IDEM Singapore 2026

Singapore, SINGAPORE